• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Vaccine . Potent priming by inactivated whole influenza virus particle vaccines is linked to viral RNA uptake into antigen presenting cells

tetano

Editor, Senior Moderator
Vaccine


. 2021 Jun 2;S0264-410X(21)00660-5.
doi: 10.1016/j.vaccine.2021.05.065. Online ahead of print.
Potent priming by inactivated whole influenza virus particle vaccines is linked to viral RNA uptake into antigen presenting cells


Masashi Shingai[SUP] 1 [/SUP], Naoki Nomura[SUP] 2 [/SUP], Toshiki Sekiya[SUP] 3 [/SUP], Marumi Ohno[SUP] 2 [/SUP], Daisuke Fujikura[SUP] 2 [/SUP], Chimuka Handabile[SUP] 2 [/SUP], Ryosuke Omori[SUP] 2 [/SUP], Yuki Ohara[SUP] 4 [/SUP], Tomohiro Nishimura[SUP] 4 [/SUP], Masafumi Endo[SUP] 4 [/SUP], Kazuhiko Kimachi[SUP] 4 [/SUP], Ryotarou Mitsumata[SUP] 5 [/SUP], Tomio Ikeda[SUP] 5 [/SUP], Hiroki Kitayama[SUP] 6 [/SUP], Hironori Hatanaka[SUP] 6 [/SUP], Tomoyoshi Sobue[SUP] 7 [/SUP], Fumihito Muro[SUP] 7 [/SUP], Saori Suzuki[SUP] 8 [/SUP], Cong Thanh Nguyen[SUP] 8 [/SUP], Hirohito Ishigaki[SUP] 8 [/SUP], Misako Nakayama[SUP] 8 [/SUP], Yuya Mori[SUP] 8 [/SUP], Yasushi Itoh[SUP] 8 [/SUP], Marios Koutsakos[SUP] 9 [/SUP], Brendon Y Chua[SUP] 9 [/SUP], Katherine Kedzierska[SUP] 9 [/SUP], Lorena E Brown[SUP] 9 [/SUP], David C Jackson[SUP] 9 [/SUP], Kazumasa Ogasawara[SUP] 8 [/SUP], Yoichiro Kino[SUP] 10 [/SUP], Hiroshi Kida[SUP] 11 [/SUP]



Affiliations

Abstract

Current detergent or ether-disrupted split vaccines (SVs) for influenza do not always induce adequate immune responses, especially in young children. This contrasts with the whole virus particle vaccines (WPVs) originally used against influenza that were immunogenic in both adults and children but were replaced by SV in the 1970s due to concerns with reactogenicity. In this study, we re-evaluated the immunogenicity of WPV and SV, prepared from the same batch of purified influenza virus, in cynomolgus macaques and confirmed that WPV is superior to SV in priming potency. In addition, we compared the ability of WPV and SV to induce innate immune responses, including the maturation of dendritic cells (DCs) in vitro. WPV stimulated greater production of inflammatory cytokines and type-I interferon in immune cells from mice and macaques compared to SV. Since these innate responses are likely triggered by the activation of pattern recognition receptors (PRRs) by viral RNA, the quantity and quality of viral RNA in each vaccine were assessed. Although the quantity of viral RNA was similar in the two vaccines, the amount of viral RNA of a length that can be recognized by PRRs was over 100-fold greater in WPV than in SV. More importantly, 1000-fold more viral RNA was delivered to DCs by WPV than by SV when exposed to preparations containing the same amount of HA protein. Furthermore, WPV induced up-regulation of the DC maturation marker CD86 on murine DCs, while SV did not. The present results suggest that the activation of antigen-presenting DCs, by PRR-recognizable viral RNA contained in WPV is responsible for the effective priming potency of WPV observed in naïve mice and macaques. WPV is thus recommended as an alternative option for seasonal influenza vaccines, especially for children.

Keywords: Inactivated whole influenza virus particle vaccine; Seasonal and pandemic influenza.
 
Back
Top Bottom